Bay Harbor Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
EHC
Bay Harbor Wealth Management's NVO Position: Q4 2019 in Review
Bay Harbor Wealth Management sold out of Novo Nordisk (NVO) in Q4 2019, closing a stake of 150 shares — an estimated $4K sold.
Bay Harbor Wealth Management first reported a position in NVO in Q4 2018 and held it in 4 quarters. The position peaked at $4K in Q3 2019. 640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.
- Bay Harbor Wealth Management reported no remaining Novo Nordisk position as of Q4 2019 after selling out during the quarter.
- Bay Harbor Wealth Management sold 150 Novo Nordisk shares in Q4 2019, an estimated $4K.
- Bay Harbor Wealth Management first reported a position in Novo Nordisk in Q4 2018 and held it in 4 quarters.
- Bay Harbor Wealth Management's Novo Nordisk position peaked at $4K in Q3 2019.
- 640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.
Based on Bay Harbor Wealth Management's 13F filing for Q4 2019, filed 27 Jan 2020.